Genotypic and Functional Impact of HIV-1 Adaptation to Its Host Population during the North American Epidemic

HLA-restricted immune escape mutations that persist following HIV transmission could gradually spread through the viral population, thereby compromising host antiviral immunity as the epidemic progresses. To assess the extent and phenotypic impact of this phenomenon in an immunogenetically diverse population, we genotypically and functionally compared linked HLA and HIV (Gag/Nef) sequences from 358 historic (1979–1989) and 382 modern (2000–2011) specimens from four key cities in the North American epidemic (New York, Boston, San Francisco, Vancouver). Inferred HIV phylogenies were star-like, with approximately two-fold greater mean pairwise distances in modern versus historic sequences. The reconstructed epidemic ancestral (founder) HIV sequence was essentially identical to the North American subtype B consensus. Consistent with gradual diversification of a “consensus-like” founder virus, the median “background” frequencies of individual HLA-associated polymorphisms in HIV (in individuals lacking the restricting HLA[s]) were ∼2-fold higher in modern versus historic HIV sequences, though these remained notably low overall (e.g. in Gag, medians were 3.7% in the 2000s versus 2.0% in the 1980s). HIV polymorphisms exhibiting the greatest relative spread were those restricted by protective HLAs. Despite these increases, when HIV sequences were analyzed as a whole, their total average burden of polymorphisms that were “pre-adapted” to the average host HLA profile was only ∼2% greater in modern versus historic eras. Furthermore, HLA-associated polymorphisms identified in historic HIV sequences were consistent with those detectable today, with none identified that could explain the few HIV codons where the inferred epidemic ancestor differed from the modern consensus. Results are therefore consistent with slow HIV adaptation to HLA, but at a rate unlikely to yield imminent negative implications for cellular immunity, at least in North America. Intriguingly, temporal changes in protein activity of patient-derived Nef (though not Gag) sequences were observed, suggesting functional implications of population-level HIV evolution on certain viral proteins.

[1]  Rosemary M. McCloskey,et al.  Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes , 2013, Retrovirology.

[2]  Laurent Tran,et al.  Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic , 2013, PLoS pathogens.

[3]  D. Richman,et al.  Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs , 2013, The Lancet.

[4]  B. Walker,et al.  Dynamic range of Nef functions in chronic HIV-1 infection. , 2013, Virology.

[5]  Victor Appay,et al.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. , 2013, Immunity.

[6]  Sergei L. Kosakovsky Pond,et al.  FUBAR: a fast, unconstrained bayesian approximation for inferring selection. , 2013, Molecular biology and evolution.

[7]  F. Pereyra,et al.  Attenuation of multiple Nef functions in HIV-1 elite controllers , 2013, Retrovirology.

[8]  David Heckerman,et al.  Significant Reductions in Gag-Protease-Mediated HIV-1 Replication Capacity during the Course of the Epidemic in Japan , 2012, Journal of Virology.

[9]  R. Siliciano,et al.  Developing strategies for HIV-1 eradication. , 2012, Trends in immunology.

[10]  Z. Brumme,et al.  HLA class I sequence-based typing using DNA recovered from frozen plasma. , 2012, Journal of immunological methods.

[11]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[12]  A. McLean,et al.  Cytotoxic T-Lymphocyte Escape Mutations Identified by HLA Association Favor Those Which Escape and Revert Rapidly , 2012, Journal of Virology.

[13]  Tommy F. Liu,et al.  Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool , 2012, Journal of Clinical Microbiology.

[14]  Huldrych F. Günthard,et al.  Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.

[15]  D. Heckerman,et al.  Widespread Impact of HLA Restriction on Immune Control and Escape Pathways of HIV-1 , 2012, Journal of Virology.

[16]  David Heckerman,et al.  Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1 , 2012, Journal of Virology.

[17]  G. Gottlieb,et al.  Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission , 2012, AIDS.

[18]  D. Heckerman,et al.  CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control , 2012, PloS one.

[19]  B. Berkhout,et al.  Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic , 2011, AIDS.

[20]  M. John,et al.  Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. , 2011, Blood.

[21]  D. Heckerman,et al.  Influence of Gag-Protease-Mediated Replication Capacity on Disease Progression in Individuals Recently Infected with HIV-1 Subtype C , 2011, Journal of Virology.

[22]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[23]  Angela R. McLean,et al.  Modelling the Evolution and Spread of HIV Immune Escape Mutants , 2010, PLoS pathogens.

[24]  Sergei L. Kosakovsky Pond,et al.  Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology , 2010, Bioinform..

[25]  Lynn Morris,et al.  Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.

[26]  Todd M. Allen,et al.  Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection , 2010, Journal of Virology.

[27]  E. Bunnik,et al.  Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level , 2010, Nature Medicine.

[28]  Evan Wood,et al.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study , 2010, The Lancet.

[29]  David Heckerman,et al.  Gag-Protease-Mediated Replication Capacity in HIV-1 Subtype C Chronic Infection: Associations with HLA Type and Clinical Parameters , 2010, Journal of Virology.

[30]  S. Buus,et al.  Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.

[31]  O. Gascuel,et al.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.

[32]  J. Mullins,et al.  Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression than HLA Genotype , 2010, Journal of Virology.

[33]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[34]  Sergei L. Kosakovsky Pond,et al.  An Evolutionary Model-Based Algorithm for Accurate Phylogenetic Breakpoint Mapping and Subtype Prediction in HIV-1 , 2009, PLoS Comput. Biol..

[35]  Ard van Sighem,et al.  Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands , 2009, PloS one.

[36]  M. Prins,et al.  Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands , 2009, AIDS.

[37]  C. Rouzioux,et al.  No evidence of a change in HIV-1 virulence since 1996 in France , 2009, AIDS (London).

[38]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[39]  D. Hazuda,et al.  The Challenge of Finding a Cure for HIV Infection , 2009, Science.

[40]  David Heckerman,et al.  HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering , 2009, Journal of Virology.

[41]  S. Frost,et al.  Detecting signatures of selection from DNA sequences using Datamonkey. , 2009, Methods in molecular biology.

[42]  Todd M. Allen,et al.  Transmission and Long-Term Stability of Compensated CD8 Escape Mutations , 2008, Journal of Virology.

[43]  C. Seoighe,et al.  Frequent Toggling between Alternative Amino Acids Is Driven by Selection in HIV-1 , 2008, PLoS pathogens.

[44]  Todd M. Allen,et al.  Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.

[45]  M. Carrington,et al.  HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus Infection , 2008, Journal of Virology.

[46]  Todd M. Allen,et al.  HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.

[47]  H. Salomón,et al.  HLA-Driven Convergence of HIV-1 Viral Subtypes B and F Toward the Adaptation to Immune Responses in Human Populations , 2008, PloS one.

[48]  David Heckerman,et al.  Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.

[49]  D. Heckerman,et al.  Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.

[50]  H. Schuitemaker,et al.  Molecular Evolution of Human Immunodeficiency Virus Type 1 upon Transmission between Human Leukocyte Antigen Disparate Donor-Recipient Pairs , 2008, PloS one.

[51]  J. Margolick,et al.  Lack of Evidence for Changing Virulence of HIV-1 in North America , 2008, PloS one.

[52]  David Heckerman,et al.  Statistical Resolution of Ambiguous HLA Typing Data , 2008, PLoS Comput. Biol..

[53]  S. Oka,et al.  CTL-Mediated Selective Pressure Influences Dynamic Evolution and Pathogenic Functions of HIV-1 Nef1 , 2008, The Journal of Immunology.

[54]  A. Rambaut,et al.  The emergence of HIV/AIDS in the Americas and beyond , 2007, Proceedings of the National Academy of Sciences.

[55]  A. Rambaut,et al.  BEAST: Bayesian evolutionary analysis by sampling trees , 2007, BMC Evolutionary Biology.

[56]  Todd M. Allen,et al.  Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication , 2007, Journal of Virology.

[57]  Ben Berkhout,et al.  Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort. , 2007, Virology.

[58]  D. Nickle,et al.  Reconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 Proteins , 2007, Journal of Virology.

[59]  Philip J. R. Goulder,et al.  Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.

[60]  B. Walker,et al.  Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression , 2007, Journal of Virology.

[61]  D. Heckerman,et al.  Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.

[62]  D. Richman,et al.  Maintenance of Nef-Mediated Modulation of Major Histocompatibility Complex Class I and CD4 after Sexual Transmission of Human Immunodeficiency Virus Type 1 , 2007, Journal of Virology.

[63]  A. Phillips,et al.  Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. , 2007, The Journal of infectious diseases.

[64]  E. Arts,et al.  Is HIV-1 evolving to a less virulent form in humans? , 2007, Nature Reviews Microbiology.

[65]  D. Nickle,et al.  Sources of variation in ancestral sequence reconstruction for HIV-1 envelope genes , 2006, Evolutionary bioinformatics online.

[66]  D. Cornforth,et al.  HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently1 , 2006, The Journal of Immunology.

[67]  Sebastian Bonhoeffer,et al.  Stable virulence levels in the HIV epidemic of Switzerland over two decades , 2006, AIDS.

[68]  B. Walker,et al.  Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[69]  S. Ho,et al.  Relaxed Phylogenetics and Dating with Confidence , 2006, PLoS biology.

[70]  Todd M. Allen,et al.  Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. , 2006, Journal of virological methods.

[71]  Mathieu Fourment,et al.  PATRISTIC: a program for calculating patristic distances and graphically comparing the components of genetic change , 2006, BMC Evolutionary Biology.

[72]  Galit Alter,et al.  De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.

[73]  E. Arts,et al.  Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time , 2005, AIDS.

[74]  D. Richman,et al.  Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance. , 2005, AIDS research and human retroviruses.

[75]  Andrew K. Sewell,et al.  Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA , 2005, The Journal of experimental medicine.

[76]  Sergei L. Kosakovsky Pond,et al.  HyPhy: hypothesis testing using phylogenies , 2005, Bioinform..

[77]  D. Cooper,et al.  Frequent Transmission of Cytotoxic-T-Lymphocyte Escape Mutants of Human Immunodeficiency Virus Type 1 in the Highly HLA-A24-Positive Japanese Population , 2004, Journal of Virology.

[78]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[79]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[80]  Stephen J O'Brien,et al.  The influence of HLA genotype on AIDS. , 2003, Annual review of medicine.

[81]  B. Walker,et al.  Gradual adaptation of HIV to human host populations: good or bad news? , 2003, Nature Medicine.

[82]  F. Kirchhoff,et al.  Enhanced CD4 Down-modulation by Late Stage HIV-1 nef Alleles Is Associated with Increased Env Incorporation and Viral Replication* , 2003, Journal of Biological Chemistry.

[83]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Anne-Mieke Vandamme,et al.  U.S. Human Immunodeficiency Virus Type 1 Epidemic: Date of Origin, Population History, and Characterization of Early Strains , 2003, Journal of Virology.

[85]  Feng Gao,et al.  Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.

[86]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[87]  M. Mulligan,et al.  Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.

[88]  M. Carrington,et al.  HLA and AIDS: a cautionary tale. , 2001, Trends in molecular medicine.

[89]  Michael Bunce,et al.  Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.

[90]  J. Bradford,et al.  The evolution of the Fenway Community Health model. , 2001, American journal of public health.

[91]  T. Greenough,et al.  Modulation of Different Human Immunodeficiency Virus Type 1 Nef Functions during Progression to AIDS , 2001, Journal of Virology.

[92]  S. Buchbinder,et al.  Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979). , 2000, AIDS research and human retroviruses.

[93]  A. Lapedes,et al.  Timing the ancestor of the HIV-1 pandemic strains. , 2000, Science.

[94]  Hiv Survival,et al.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.

[95]  F. Marincola,et al.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[96]  E. Vittinghoff,et al.  Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. , 1999, American journal of epidemiology.

[97]  T. Heeren,et al.  The social context of drinking, drug use, and unsafe sex in the Boston Young Men Study. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[98]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[99]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[100]  I. Keet,et al.  Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. , 1996, AIDS.

[101]  R. Swanstrom,et al.  Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo , 1993, Journal of virology.

[102]  S. Buchbinder,et al.  Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990. , 1993, American journal of epidemiology.

[103]  S. Rowland-Jones,et al.  Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. , 1992, AIDS research and human retroviruses.

[104]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.

[105]  G. Rutherford,et al.  Estimating AIDS infection rates in the San Francisco cohort. , 1988, AIDS.

[106]  M. Schechter,et al.  The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[107]  B. Wiggs,et al.  The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. , 1985, Canadian Medical Association journal.

[108]  M. Schechter,et al.  The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy. , 1985, Canadian Medical Association journal.